Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a need for better tools to guide treatment selection and follow‐up. The aim of this prospective study was to investigate the prognostic value and treatment monitoring potential of longitudinal circulating tumour DNA (ctDNA) measurement...

Descripción completa

Detalles Bibliográficos
Autores principales: Edland, Karin Hestnes, Tjensvoll, Kjersti, Oltedal, Satu, Dalen, Ingvild, Lapin, Morten, Garresori, Herish, Glenjen, Nils, Gilje, Bjørnar, Nordgård, Oddmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483602/
https://www.ncbi.nlm.nih.gov/pubmed/37341038
http://dx.doi.org/10.1002/1878-0261.13472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483602/
https://www.ncbi.nlm.nih.gov/pubmed/37341038
http://dx.doi.org/10.1002/1878-0261.13472

Ejemplares similares